Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Solid Tumors.
Clinical trial NCT05864014 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05864014
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-25
- Primary completion
- 2025-03-03
- Enrollment
- 213
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.